CLINICAL_TRIALS ClinicalTrials.gov record update

Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol® Followed by Gelfoam® Embolization

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04728633
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:29.818521+00:00
Published At: 2025-08-06T00:00:00+00:00
Record Updated At: 2025-08-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Malignant Neoplasm in the Liver", "Metastatic Uveal Melanoma", "Stage IV Choroidal and Ciliary Body Melanoma AJCC V8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-06"
protocolSection.identificationModule.nctId: "NCT04728633"
protocolSection.identificationModule.officialTitle: "Chemoembolization of Uveal Melanoma Hepatic Metastases Using 300mg of BCNU Dissolved in Lipiodol\u00ae Followed by Gelfoam\u00ae Embolization"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.